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doi:10.1016/j.ejvs.2009.11.034Abstract Objectives: The purpose of this study was to assess the impact of renal insuffi-
ciency (RI) on the distribution pattern of peripheral arterial disease (PAD). We hypothesised
that RI is associated with a distally accentuated involvement of the peripheral arterial tree.
Design: This is a retrospective analysis.
Materials and Methods: Analysis was based on a consecutive series of 2709 patients with
chronic PAD of atherosclerotic origin undergoing primary endovascular treatment of lower-
extremity arteries. Atherosclerotic pattern was grouped into femoropopliteal (nZ 2085) and
infragenicular (nZ 892) disease according to target lesions treated while using iliac disease
(nZ 1133) as reference. Univariable and multivariable multinomial regression analyses were
performed to assess relation with RI. Results are shown as relative risk ratio (RRRs) with 95%
confidence intervals (95% CIs). A p< 0.05 was considered statistically significant. RI was
defined as glomerular filtration rate (GFR)< 60 ml min1 1.73 m2.
Results: Presence of RI was an independent risk factor for a centrifugal lesion pattern (RRR
1.48, 95% CI: 1.17e1.86, pZ 0.001). Moreover, a decrease in GFR by 10 ml min1 1.73 m2
was associated with an RRR of 1.08 for below-the-knee arterial disease (95% CI: 1.03e1.13,
pZ 0.003).
Conclusion: Presence and severity of RI are independent predictors of a distal obstructive
pattern in patients with symptomatic PAD.
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Atherosclerosis and its complications are the leading cause
of death in Western world.1,2 Interestingly, while patho-
physiological mechanisms are similar throughout the
arterial vascular tree, it seems that cardiovascular risk
factors induce a differential modulation of the disease
progression and clinical phenotype of atherosclerotic
disease process.3e9 Cigarette smoking and hyper-
cholesterolaemia were shown to have a major impact on
the incidence of coronary artery disease, while arterial
hypertension and diabetes mellitus have an influence on
the incidence of cerebrovascular disease;3,4 and in the
lower limb arterial tree, atherosclerotic manifestations
were shown to be predominantly related to smoking and
diabetes mellitus.4,5 A high prevalence and incidence of
PAD is also known for patients with chronic kidney
disease(CKD);6,7 and cardiovascular events are the leading
cause of morbidity and mortality in patients with end-
stage renal disease.8,9 Little is known about the patho-
physiological mechanism and its impact on the distribution
pattern in PAD. With a substantially increasing prevalence
of chronic renal failure10,11 strongly influenced by the
epidemic increase of diabetes mellitus,12 the treatment of
atherosclerosis in this patient group will remain an
important challenge for physicians in the future.
To date, despite the frequent coincidence of RI and
diabetes mellitus, the impact of renal disease on lower-
limb atherosclerosis is limited to anecdotal observation and
has not been systematically evaluated.13e15 The aim of the
present study was to scrutinise the association of RI and
distribution pattern of atherosclerotic lower-limb lesions in
patients with symptomatic PAD. Based on clinical observa-
tions, we hypothesised that the presence of RI is associated
with distinct below-the-knee arterial disease.
Materials and Methods
A total of 2709 consecutive patients (1048 women, mean
age 70.6 11.5 years) with symptomatic chronic PAD and
primary angioplasty (stenting) of lower-limb arteries
(3331 limbs and 4110 target lesions) in a tertiary referral
centre for peripheral vascular service responsible for
a population of about 1 million inhabitants were included in
the present analysis between January 1995 and May 2008.
Only patients presenting the first time for endovascular
treatment were included in the analysis. Patients with
acute limb ischaemia (88 patients during time span of data
collection) or redo interventions were excluded. Prior to
endovascular revascularisation, all patients had undergone
clinical work-up and arterial duplex ultrasound to confirm
findings suspected by clinical examination.
Target lesions treated defined relevant atherosclerotic
disease manifestation. Location of target lesions was
grouped as iliac (common and external and internal iliac
artery), femoropopliteal (common, superficial and deep
femoral arteries and popliteal artery) and infragenicular
(tibioperoneal trunk, anterior and posterior tibial arteries
and peroneal artery) disease. In case of multi-level disease,
every treated lesion accounted once for the corresponding
group. According to our institutional policy, patientsundergo full revascularisation during the same hospital-
isation, that is, no patient undergoes a two-step interven-
tional procedure for iliac and femoropopliteal target
lesions.
The present study complied with the Declaration of
Helsinki.16
Renal insufficiency was defined by glomerular filtration
rate (GFR) <60 ml min1 per 1.73 m2 estimated by ‘four-
variable MDRD’ (Modification of Diet in Renal Disease)
formula according to the National Kidney Foundation (NKF)
Kidney Disease Outcomes Quality Initiative (KDOQI)
guidelines.17 Patients were grouped into chronic kidney
disease stage 1 to 5 (stage 1: GFR above 90 ml min1 per
1.73 m2, stage 2: GFR of 60e89 ml min1 per 1.73 m2,
stage 3: GFR of 30e59 ml min1 per 1.73 m2, stage 4: GFR of
15e29 ml min1 per 1.73 m2, stage 5: GFR less than
15 ml min1 per 1.73 m2).17 Diagnosis of diabetes mellitus
was defined by fasting blood sugar >120 mg dl1 or glyco-
sylated haemoglobin >6% or if the patient was on hypo-
glycaemic drugs.18 Presence of arterial hypertension was
defined by systolic blood pressure >140 mmHg and/or dia-
stolic blood pressure>80 mmHg, or if the patient consumed
any antihypertensive drug.18 Presence of hyperlipidaemia
was defined by total cholesterol level >5 mmol l1 or high-
density lipoprotein (HDL) cholesterol <1 mmol l1, or
triglycerides >2 mmol l1, or if the patient consumed any
lipid-lowering drug.18 Furthermore, patients were classi-
fied as smokers and non-smokers. A smoking history (current
or former smokers) was established in patients who had one
pack-year or more of tobacco use based on patient inter-
view or chart documentation.18
Statistical analyses were performed at the Institute of
Social and Preventive Medicine, University of Bern,
Switzerland. Descriptive analyses of socio-demographic
characteristics were based on patient characteristics at the
time of the first intervention. Demographic and clinical
characteristics of study population are reported as
mean SD for continuous variables and as number
(percentage) for categorical variables. Each target lesion
was counted once and classified according to its location as
iliac, femoropopliteal and infragenicular disease.
Statistical analysis focussed on impaired renal function
as a risk factor for distal PAD. RI was defined as GFR
<60 mlmin1 per 1.73 m2.
Data were stratified in a binary (RI yes/no), grouped
(normal renal function: GFR >90 mlmin1 per 1.73 m2; mild
RI: GFR 60e89 mlmin1 per 1.73 m2; moderate RI: GFR
30e59 mlmin1 per 1.73 m2; severe RI: GFR 15e29 ml min1
per 1.73 m2; and kidney failure GFR <15 ml min1 per
1.73 m2) and continuous manner.
A multivariable multinomial logistic regression was used
to analyse risk factor associations with the level of lesions.
Iliac lesions were chosen as the reference category. Since
some patients had more than one target lesion, robust
standard errors were used to allow for the multilevel nature
of the data. Risk factors included in the statistical model
were diabetes mellitus, arterial hypertension, hyper-
lipidaemia, cigarette smoking, male sex and age.18
Results are shown as relative risk ratio (RRR) with 95%
confidence intervals (95%- CIs). A p< 0.05 was considered
statistically significant. All analyses were performed in Stata
version 10.1 (Stata Corporation, College Station, TX, USA).
Table 1 Descriptive data of the 2709 patients included in the study additionally classified according to the degree of renal
insufficiency (stage 1e5).
Patient characteristics All Stage 1a Stage 2b Stage 3c Stage 4d Stage 5e
Patients, n (%) 2709 (100) 289 (10.7) 1130 (41.7) 1070 (39.5) 147 (5.4) 73 (2.7)
Age (mean SD), years 70.6 11.5 62.3 11.7 67.5 11.3 75.4 9.4 76.6 9.3 67.1 10.0
Male gender, n (%) 1661 (61.3) 240 (83.0) 800 (70.8) 508 (47.5) 68 (46.3) 45 (61.6)
Diabetes mellitus, n (%) 934 (34.5) 81 (28.0) 323 (28.6) 404 (37.8) 83 (56.5) 43 (58.9)
Hypertension, n (%) 1771 (65.4) 186 (64.4) 661 (58.5) 752 (70.3) 113 (76.9) 59 (80.8)
Hyperlipidemia, n (%) 1405 (51.9) 164 (56.8) 613 (54.3) 516 (48.2) 67 (45.6) 45 (61.6)
Smoking, n (%) 1380 (50.9) 217 (75.1) 693 (61.3) 408 (38.1) 37 (25.2) 25 (34.3)
CAD,f n (%) 749 (28.2) 55 (20.1) 255 (22.9) 360 (34.1) 51 (35.4) 28 (38.4)
CVD,g n (%) 148 (5.5) 18 (6.3) 39 (3.5) 81 (7.6) 7 (4.8) 3 (4.2)
Bilateral disease, n (%) 622 (23.0) 56 (19.4) 287 (25.4) 254 (23.7) 15 (10.2) 10 (13.7)
Multilevel disease, n (%) 838 (30.9) 79 (27.3) 308 (27.3) 369 (34.5) 55 (37.4) 27 (37.0)
Mean GFR SD 62 24 108 16 73 8 48 8 25 4 9 3
a GFR >90 mL/min/1.73 m2.
b GFR 60e89 mL/min/1.73 m2.
c GFR 30e59 mL/min/1.73 m2.
d GFR 15e29 mL/min/1.73 m2.
e GFR <15 mL/min/1.73 m2.
f Coronary artery disease.
g Cerebrovascular disease.
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Descriptive data of study patients is given in Table 1.
Number of treated limbs was 3331 (4110 target lesions).
Target lesions were allocated to the three pre-defined
anatomic regions as iliac (nZ 1133), femoropopliteal
(nZ 2085) and infragenicular (nZ 892).
Results from univariable and multivariable multinominal
logistic regression analysis showing the association between
RI and distribution pattern of symptomatic lower limb
arterial obstructive lesions are given in Tables 2 and 3. RI
was an independent predictor for infragenicular disease
involvement.
Univariable analysis showed an increased risk for presence
of atherosclerotic lesions in the femoropoliteal and more
pronounced in the infragenicular as compared with the iliac
segment, respectively (Table 2). The grade of RI correlatedTable 2 Influence of renal insufficiency on the distribution pat
Univariable regression analysis for femoropopliteal and infrageni
Risk factor Atherosclerotic lesions
Iliac (reference) Femoropolite
RRR RRR 95%
RIa (yes/no) 1 2.08 1.77
Moderate RIb (vs. no RI) 1 2.64 2.05
Severe RIc (vs. no RI) 1 3.17 2.06
Kidney failured (vs. no RI) 1 6.27 2.53
GFR incremente 1 1.18 1.14
a Renal insufficiency (RI): defined as GFR< 60 mL/min/1.73 m2.
b Moderate RI: defined as GFR 30e59 mL/min/1.73 m2.
c Severe RI: defined as GFR 15e29 mL/min/1.73 m2.
d Kidney failure: defined as GFR< 15 mL/min/1.73 m2.
e Estimated for an increase of 10 mL/min/1.73 m2 of GFR.with an increasing probability for the presence of infrage-
nicular arterial obstructions (all p< 0.0001). Continuous
analysis of GFR levels demonstrated that a decrease in GFR by
10 mlmin1 per 1.73 m2 was associated with a RRR of 1.30 for
distal disease involvement (95% CI: 1.24e1.37, p< 0.0001).
After adjustment for age, male sex, diabetes mellitus,
arterial hypertension, hyperlipidaemia and current smoking
by multinominal regression analysis, the observation of
a centrifugal lesion pattern in patients with impaired renal
function remained statistically significant (Table 3). Pres-
ence of RI was associated with an increased risk for rele-
vant infragenicular arterial disease (RRR 1.48, 95% CI:
1.17e1.86, pZ 0.001). Furthermore, a decrease in GFR
levels by 10 ml min1 per 1.73 m2 was associated with an
increased probability for the presence of distal disease
involvement (RRR 1.08, 95% CI: 1.03 1.13, pZ 0.003).
Finally, end-stage renal disease was an independenttern of atherosclerotic lesions in peripheral arterial disease.
cular disease manifestation.
al Infragenicular
-CI p RRR 95%-CI p
e2.45 <0.0001 3.2 2.61e3.94 <0.0001
e3.39 <0.0001 3.44 2.43e4.86 <0.0001
e4.89 <0.0001 5.02 2.94e8.56 <0.0001
e15.53 <0.0001 16.30 6.32e42.06 <0.0001
e1.21 <0.0001 1.30 1.24e1.37 <0.0001
Figure 1 Digital subtraction angiography in a patient with end-stage renal disease and critical limb ischemia. Diffuse severe
calcification along the superficial femoral artery (A), occlusion of the distal anterior tibial and proximal peroneal arteries and
complete occlusion of the posterior tibial artery (B), occlusion of the plantar and dorsal arterial arches at the foot level (C).
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95% CI: 3.0e19.88, p< 0.0001). In the grouped analysis,
a tendency for distal disease involvement was observed for
moderate RI (RRR 1.05, 95% CI: 0.72e1.54, pZ 0.804), but
these findings did not reach statistical significance. For
patients with severe RI, no correlation with a distal distri-
bution pattern of PAD could be demonstrated.
A similar centrifugal obstructive lesion pattern in
multivariable multinominal regression analysis was
observed in patients with diabetes mellitus (RRR 3.26, 95%
CI 2.59e3.11, p< 0.0001) and increased age (RRR per
1-year increment 1.06, 95% CI: 1.05e1.07, p< 0.0001),
both independent from the presence of RI. Current or
former smoking was inversely associated with distal disease
involvement (RRR 0.23, 95% CI: 0.17e0.29, p< 0.0001).Table 3 Influence of renal insufficiency on the distribution pat
Multivariable multinominal regression analysis for femoropoplitea
diabetes mellitus, arterial hypertension, hyperlipidemia, cigarett
Risk factor Atherosclerotic lesions
Iliac (reference) Femoropop
RRR RRR 9
RIa (yes/no) 1 1.11 0
Moderate RIb (vs. no RI) 1 1.04 0
Severe RIc (vs. no RI) 1 0.92 0
Kidney failured (vs. no RI) 1 3.64 1
GFR incremente 1 1.02 0
a Renal insufficiency (RI): defined as GFR< 60 mL/min/1.73 m2.
b Moderate RI: defined as GFR 30e59 mL/min/1.73 m2.
c Severe RI: defined as GFR 15e29 mL/min/1.73 m2.
d Kidney failure: defined as GFR< 15 mL/min/1.73 m2.
e Estimated for an increase of 10 mL/min/1.73 m2 of GFR.Prevalence of multilevel PAD and cardiovascular disease
was higher in patients with RI, whereas cerebrovascular
disease did not show this association (Table 1).Discussion
This large cohort of patients with symptomatic PAD high-
lights a significant independent association between RI and
below-the-knee arterial disease (Fig. 1). A very similar
atherosclerotic phenotype has been described in associa-
tion with diabetes mellitus and advanced age.18e21
Current hypotheses potentially explaining the site
selectivity of atherosclerotic lesions include shear stress
related to arterial geometry and anatomic, cellular ortern of atherosclerotic lesions in peripheral arterial disease.
l and infragenicular disease manifestation (data adjusted for
e smoking, male gender and age).
liteal Infragenicular
5%-CI p RRR 95%-CI p
.93e1.34 0.252 1.48 1.17e1.86 0.001
.78e1.38 0.775 1.05 0.72e1.54 0.804
.57e1.48 0.727 0.94 0.52e1.71 0.840
.51e8.81 0.004 7.72 3.0e19.88 <0.0001
.98e1.05 0.327 1.08 1.03e1.13 0.003
Lower-limb Atherosclerosis and Renal Insufficiency 595biochemical characteristics of the arterial wall.19,22,23
Histological structure of lower extremity arteries changes
from proximal to distal. Whereas iliac arteries consist of
more elastic elements, femoral and infragenicular arteries
are characterised by an increased amount of muscular
components. Moreover, the relation of arterial lumen to
wall thickness decreases from proximal to distal, both
generating an alteration in arterial flow, oscillation and
shear stress associated with endothelial dysfunction and
early atherosclerotic lesions at sites with low shear rate
and disturbed flow.18
Given the novel concepts regarding the pathogenesis of
atherosclerosis,24e26 it is suggestive that the comparable
distribution pattern of lower limb arterial obstructions in
diabetic and renally impaired patients may be attributable
to a similar pathophysiology of arterial calcification in these
two patient groups. Pathogenesis of atherosclerosis is today
no longer simply looked upon as passive precipitation of
calcium and phosphate in supersaturated plasma. In fact,
the aetiology of vascular calcification is mainly dependent
on complex molecular and cellular interactions leading to
atypical mineralisation resulting from an imbalance of
promotion and inhibition of mineralisation.26 Several
studies indicate that a phenotypic change of vascular
smooth muscle cells (VSMCs) to osteoblastic cells is a key
factor of arterial calcification.24e28
In diabetic patients, hyperglycaemia, free fatty acid
release and insulin resistance can cause endothelial
changes that lead to augmented vasoconstriction,
increased inflammation and a hypercoaguable state
promoting thrombosis. Within this cascade, VSMC dysfunc-
tion is known to have an integral influence on the devel-
opment of atherosclerosis due to extracellular matrix
deposition in intimal lipid-rich lesions and a general cell
growth contributing to increased vasoconstriction.24 More-
over, hyperglycaemia stimulates VSMCs to produce reactive
oxygen species contributing to the oxidant-rich milieu in
atherosclerotic lesions.29
To date, the precise pathophysiology of vascular calci-
fication in RI remains unclear. However, several studies
have linked vascular calcification in RI to the induction of
VSMC calcification due to elevated serum calcium and
phosphate levels or uraemic toxins.25,30e32
Inflammation has also been linked to the promotion of
VSMC calcification33 and a higher burden of chronic
inflammation is known for both patients with chronic RI and
diabetes mellitus. VSMC dysfunction seems to be a key
factor in the development of atherosclerosis in patients
with chronic kidney disease or diabetes mellitus. Given that
VSMCs are abundant in smaller vessels such as the infra-
genicular arteries, we assume that both histological
prerequisites and pathophysiological similarities might
explain the similar distribution pattern of PAD in those two
patient groups.
Studies on vascular calcification in patients with RI have
mostly been performed in end-stage renal disease but
growing evidence indicates that already moderate RI
promotes vascular calcification.8,34 Consistent with these
findings, an increase in arterial stiffness predominantly in
small vessels associated with early kidney dysfunction has
been described.35 Interestingly, a correlation of small-
vessel atherosclerosis with moderate renal insufficiencywas confirmed by our study, thereby corroborating the
above-mentioned associations.
The following limitations of our study have to be
addressed. First, obstructive lesion pattern in the present
study was defined by endovascular target lesions treated.
Consequently, the entire atherosclerotic burden was not
considered for analysis and patients undergoing surgical
revascularisation were not represented in the present
study. However, considering that our institutional protocol
stipulates an endovascular-first strategy in both claudicants
and patients with critical limb ischaemia36 we feel that the
data set represents a clinical real-life scenario. Moreover,
PTA target lesions represent clinically relevant athero-
sclerosis, although information about early atherosclerotic
lesions is missing. Second, we are aware that grouping the
treated vessels into three categories might be an over-
simplification. We feel, however, that a more differenti-
ated analysis of vascular territories would not have changed
our basic message. The present study does not contain
information on clinical and angiographic recurrence rates
comparing patients with renal impairment to those without
renal impairment. Third, as it is known that GFR is regularly
underestimated in healthy patients when using the MDRD
formula to estimate GFR,37 we might have overestimated
the number of patients with RI and thereby weakened the
statistical significance of our results. Finally, we cannot
rule out a bias created by only including patients selected
for endovascular therapy.
In conclusion, we demonstrated that presence of RI is an
independent predictor of a distal obstructive pattern in
patients with symptomatic PAD and that the probability of
distal disease manifestation increases with its severity. Site
selectivity of atherosclerosis in this patient group might be
related to given anatomical and histological structures and
complex pathophysiological molecular mechanisms. Further
studies on the similarities and differences in the pathogen-
esis of atherosclerosis in patients with diabetes mellitus and
RI are warranted. Due to the rapidly increasing number of
patients with diabetes mellitus and RI an improved under-
standing of the pathophysiological mechanisms in these
patient subgroups is mandatory and might lead to more
specific treatment options in the future.
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